Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Immune cells from your own tumor may fight advanced melanoma
Disease control CompletedThis study tested a one-time treatment using a patient's own immune cells (called tumor-infiltrating lymphocytes, or TILs) to fight advanced melanoma that had spread. 220 adults with stage IIIc or IV melanoma who had already tried other treatments received these specially grown c…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
Experimental cell therapy shows early promise in Tough-to-Treat blood cancers
Disease control CompletedThis early-phase study tested a new cell therapy called IOV-2001 in 7 people with chronic lymphocytic leukemia or small lymphocytic lymphoma that had stopped responding to standard drugs. The treatment uses a patient's own immune cells, which are multiplied in a lab and given bac…
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC